loading page

Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19
  • +3
  • Ricardo Pena Silva,
  • Stephen Duffull,
  • Andrew Steer,
  • Sandra Jaramillo Rincon,
  • Amanda Gwee,
  • Xiao Zhu
Ricardo Pena Silva
Universidad de los Andes
Author Profile
Stephen Duffull
University of Otago
Author Profile
Andrew Steer
Murdoch Childrens Research Institute
Author Profile
Sandra Jaramillo Rincon
Universidad de los Andes
Author Profile
Amanda Gwee
The Royal Children's Hospital Melbourne
Author Profile
Xiao Zhu
University of Otago
Author Profile

Peer review status:ACCEPTED

28 Apr 2020Submitted to British Journal of Clinical Pharmacology
29 Apr 2020Submission Checks Completed
29 Apr 2020Assigned to Editor
04 May 2020Reviewer(s) Assigned
20 May 2020Review(s) Completed, Editorial Evaluation Pending
21 May 2020Editorial Decision: Revise Minor
02 Jun 20201st Revision Received
09 Jun 2020Submission Checks Completed
09 Jun 2020Assigned to Editor
09 Jun 2020Review(s) Completed, Editorial Evaluation Pending
16 Jun 2020Editorial Decision: Accept